Olafur Gudmundsson

Olafur Gudmundsson has extensive experience in quality management within the pharmaceutical and medical device sectors, currently serving as the Director of Global Quality Service for Iceland and Nitrosamine WS lead at Teva Pharmaceuticals since January 2017. Prior roles at Teva include Associate Director of Third Party Quality Europe and Sr. Quality Relationship Manager. Olafur's tenure at Actavis began in June 2003, where responsibilities have included managing the Medical Device quality system in compliance with ISO 13485, overseeing technical agreements, and acting as Lead Auditor. Educational background includes a B.Sc. in Biology from Háskóli Íslands and further studies at DTU - Technical University of Denmark.